New senate bill cuts proposed device industry fee
This article was originally published in RAJ Devices
The US Senate has voted 60-39 in favour of holding a debate on a healthcare reform bill unveiled last week by Harry Reid (Democrat – Nevada), marking a significant victory for the Senate majority leader as well as for President Barack Obama1. Most notably, this latest bill would impose an annual fee of $2 billion on the medical devices industry, whereas earlier Senate versions had proposed a $4 billion annual fee2.
You may also be interested in...
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.
In the age of coronavirus, human factors professionals are doing their best to find their way through the pandemic by putting unique twists on usability testing to see what works and what doesn’t in the new reality. That’s the topic of this week’s podcast.